Sort
8,912 grants matching “sars cov 2”
Molecular Characterization Of The Mitochondrial Dna Polymerase
$1,500,500William Copeland · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
SUPPLEMENTAL WORK - SARS-COV-2 PRECLINICAL WORK
$1,500,152Laurie Sower · Chrysalis Biotherapeutics, Inc. · N01 · FY2020 · AI
Characterization of the antibody responses elicited upon SARS-CoV-2 infection
$1,500,000Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2020 · AI
DMID Clinical Research Operations & Management Support (CROMS), SARS-CoV-2
$1,500,000Jessica Ellis · Technical Resources International, Inc. · N01 · FY2024 · AI
A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial
$1,500,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R44 · FY2023 · HL
IP21-002, Surveillance for Vaccine Preventable Disease in Children
$1,500,000Julie Anne Boom · Baylor College Of Medicine · U01 · FY2025 · IP
Novel Protease Inhibitors as SARS Therapeutics
$1,499,929Michael E. Johnson · University Of Illinois At Chicago · P01 · FY2006 · AI
COVID 19 Supplemental work: HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY
$1,499,726George Sigal · Meso Scale Diagnostics, Llc · N01 · FY2020 · AI
Novel Protease Inhibitors as SARS Therapeutics
$1,497,577Michael E. Johnson · University Of Illinois At Chicago · P01 · FY2007 · AI
Nmr Studies Of The Regulation Of Cell Signaling
$1,495,094Nico Tjandra · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Wastewater Analysis of SARS CoV-2 in Tribal Communities
$1,494,765Otakuye Conroy-Ben · Arizona State University-Tempe Campus · U01 · FY2021 · DA
Facility Management, Maintenance and Operation Core
$1,493,669Raymond Paul Goodrich · Colorado State University · UC7 · FY2024 · AI
Etiology and outcome of MIS-C
$1,491,907Betty Diamond · Feinstein Institute For Medical Research · U19 · FY2020 · AI
Mobile Health-Targeted SARS-CoV-2 Testing and Community Interventions to Maximize Migrant Children's School Attendance During the COVID-19 Pandemic
$1,491,525Russell James McCulloh · University Of Nebraska Medical Center · OT2 · FY2022 · HD
TNPRC Breeding Colony Expansion in Support of COVID-19 Research
$1,490,575Lee Hamm · Tulane University Of Louisiana · P51 · FY2021 · OD
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression
$1,486,653Leslee J Shaw · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · HL
Maintenance of an SPF Macaque Breeding Colony for AIDS Research
$1,486,592Kasi E Russell-Lodrigue · Tulane University Of Louisiana · U42 · FY2025 · OD
Probing functioning lung at the cellular resolution in health and disease
$1,485,000Hadi Tavakoli Nia · Boston University (Charles River Campus) · DP2 · FY2022 · HL
Stanford/UNC Biomimetic U19 Research Center
$1,484,612Calvin J Kuo · Stanford University · U19 · FY2024 · AI
Production Of HIV And HIV Related Proteins For Structural Studies
$1,484,352Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Causes of Sex Differences in male and female offspring born from inflammation mediated hypertensive pregnancy
$1,482,650Babbette Babbette Lamarca · University Of Mississippi Med Ctr · U54 · FY2025 · HL
Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapies
$1,481,031Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
CEIRR: SARS-CoV-2 Research Activities
$1,480,769Walter Orenstein · Emory University · N01 · FY2021 · AI
fMRI Studies of Risk for Mood and Anxiety Disorders in Children
$1,480,585Daniel Pine · National Institute Of Mental Health · ZIA · FY2024 · MH
International Research in Cambodia: Tropical Medicine and Vector Research
$1,479,224Christina Yek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI